|
RFC1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.74240000047921E-07 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.350500E-04 |
| Normal-vs-Stage2 |
2.778500E-02 |
| Normal-vs-Stage3 |
7.5816997124889E-10 |
| Normal-vs-Stage4 |
3.61849999963582E-07 |
| Stage1-vs-Stage2 |
8.183600E-01 |
| Stage1-vs-Stage3 |
1.213940E-04 |
| Stage1-vs-Stage4 |
5.161000E-03 |
| Stage2-vs-Stage3 |
5.899700E-02 |
| Stage2-vs-Stage4 |
1.333370E-01 |
| Stage3-vs-Stage4 |
6.563200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.36460000042116E-07 |
| Normal-vs-AfricanAmerican |
2.47179999999236E-05 |
| Normal-vs-Asian |
5.252200E-01 |
| Caucasian-vs-AfricanAmerican |
3.851800E-01 |
| Caucasian-vs-Asian |
3.440600E-01 |
| AfricanAmerican-vs-Asian |
1.891380E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.70590000014847E-07 |
| Normal-vs-Female |
1.603840E-04 |
| Male-vs-Female |
1.760550E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.115480E-03 |
| Normal-vs-Age(41-60Yrs) |
2.987100E-04 |
| Normal-vs-Age(61-80Yrs) |
1.32189999946242E-07 |
| Normal-vs-Age(81-100Yrs) |
1.214950E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.137800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.429800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.220400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.394000E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.212030E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.934400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.622770E-01 |
| Normal-vs-Grade 2 |
1.523850E-03 |
| Normal-vs-Grade 3 |
8.36280000804379E-09 |
| Normal-vs-Grade 4 |
2.26409999637411E-08 |
| Grade 1-vs-Grade 2 |
1.513820E-02 |
| Grade 1-vs-Grade 3 |
3.70630000000594E-05 |
| Grade 1-vs-Grade 4 |
3.74859999999755E-05 |
| Grade 2-vs-Grade 3 |
1.503830E-03 |
| Grade 2-vs-Grade 4 |
1.876220E-03 |
| Grade 3-vs-Grade 4 |
2.618400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
5.502200E-02 |
| Normal-vs-ccB subtype |
9.5665000365841E-09 |
| ccA subtype-vs-ccB subtype |
1.30779999996111E-06 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.56419999999924E-06 |
| Normal-vs-N1 |
1.459650E-02 |
| N0-vs-N1 |
8.348000E-01 |
|
|
